Many transfusion reactions are iatrogenic in origin and reflect a lack of understanding of the indications for transfusion as well as a failure to appreciate what can be achieved with this form of therapy. The importance of anticipating problems before they arise is illustrated by a consideration of the indications for blood transfusion in several clinical situations: e.g. neonatal transfusion -exchange or replacement, cardiopulmonary by-pass, specific organ failure (cardiovascular system, the liver and the kidney) and auto-immune haemolytic anaemia. Various potentially adverse reactions are considered primarily with a view to their avoidance.
INTRODUCTION
In 1964 William H. Crosby' wrote that "the practice of blood transfusion has evolved in this century from a hit-or-miss barbarism to a relatively sophisticated therapeutic procedure". There is no doubt that, since this comment was made, the state of the art has continued to expand rapidly. In the wake of this development has come an increasing awareness of the adverse reactions that can, and do, arise from this form of therapy. Many of the problems that occur are iatrogenic in origin and reflect:-1. a lack of understanding of the indications for blood transfusion, 2. failure to appreciate what is, and what is not, possible to achieve from blood transfusion, 3. failure to anticipate potential trouble.
At the same time it is necessary to appreciate that previously unknown adverse reactions may accompany the introduction of newer and more complex therapeutic procedures. 'F.R.C.P.A.
Previous speakers have drawn attention to the various problem areas associated with transfusion and have dealt with the different effects of the quality and quantity of infused materials as well as the laboratory investigations to be undertaken. In this presentation I propose to consider several specific situations and to draw your attention to the potential hazards that may arise.
The particular clinical situations to be considered include:-1. The total blood volume of a newborn baby varies from 250-350 ml in the normal full-term infant to 100-200 ml in the premature infant. Circulatory overload is thus a hazard that must be avoided. Despite a reasonable capacity for vasodilatation any significant increase in the red cell mass raises the blood viscosity and impairs pulmonary perfusion which, due to the hypoxic state induced, may stimulate an increase in platelets 2 and release of tissue thromboplastin. The end result is intravascular occlusion with intrapulmonary shunting and the onset of the respiratory distress syndrome. 3 While hypervolaemia is a potential hazard, at the same time it is important to avoid hypovolaemia. Meticulous monitoring of blood removed and given will help ensure maintenance of normal blood volume.
Usually transfusion is performed using the umbilical vein. The use of the umbilical artery is a hazardous procedure and should be selected only as a last resort. Transmission of disease as well as postexchange sepsis are still potential problems and reflect errors in asepsis as well as selection of donor blood.
Infections with HBsAg and cytomegalovirus are still to be prevented and post-transfusion malaria continues to occur occasionally. Mallin et al. 4 drew attention to the problems of malaria in donors who had served in war zones in which malaria is endemic, and with increasing overseas travel, the possibility of a blood donor being a carrier of malaria must not be ignored.
The following are all potential hazards albeit theoretical in some cases.
Potassium excess Sodium excess Calcium excess Calcium deficiency Hypoglycaemia Acidosis or alkalosis "Citrate intoxication" Most paediatricians request blood as fresh as possible for exchange transfusion with an upper limit of storage of 5 days. The rationale for this selection is the belief that blood older than 5 days contains too much potassium and too many effete red cells for the baby to handle with safety.
With very ill premature babies there may be a poor capacity to deal with calcium imbalance, particularly hypocalcaemia, and calcium supplement may have to be given to these infants. Freshly drawn heparinised blood has been recommended for use in exchange transfusion; however, there is no real evidence to support the use of heparin over ACD or CPD, and the short shelf-life of heparinised units may lead to much wastage of blood.
(iv) Coagulation
Over-heparinisation Haemorrhage Thrombocytopenia Exchange transfusion is carried out with blood that has very little deficit in coagulation factors, hence disturbances of the coagulation mechanism should not occur. A dilutional thrombocytopenia can be demonstrated not uncommonly and some petechiae observed occasionally. However, in the absence of a source of haemorrhage, these findings are of no significance. Excess citrate does not appear to be a problem.
(v) Miscellaneous Incompatible blood transfusion Mechanical injury to cells Thermal injury to cells Hyperviscosity syndrome Hypothermia Obstructive jaundice Transfusion with incompatible blood, thermal or mechanical injury to the red cells and hypothermia are problems that may arise from time to time but they are preventable with a little care.
One problem that is receiving more attention at present is the hyperviscosity syndrome or polycythaemia of the newborn which may result from the use of red cell concentrates for the exchange procedure.
The effect of haematocrit on blood viscosity is not simple,s however, as a general rule there is virtually a straight-line relationship over the normal range of the packed cell volume. 3 Above the upper limit of normal on the other hand, there are progressively large increases in viscosity with small increases in the haematocrit. Polycythaemia may not affect full-term babies to any great extent, but premature babies tolerate it poorly. High blood viscosity always leads to circulatory slowdown and reduced tisue oxygenation and, as a consequence, there is a very real risk of inducing a "pulmonary hypoperfusion syndrome" .' (b) Replacement transfusion Replacement transfusion in the neonatal patient can induce the same adverse reactions that may be seen in the adult.
The use of a "Paediatric Pack" -4 or 5 x 100 ml interconnected packs from the one donation -lessens the risk of circulatory overload and makes for less wastage of blood. There is also less exposure to foreign antigens as the same donor can be used for successive transfusions when indicated. In the same fashion a number of centres make use of the socalled "walking donor panel".
Reconstituted frozen red cells are very costly but have much to recommend them in that they are functionally equivalent to cells of 5 days or less shelf life," and have a higher haematocrit than the average unit of packed cells. Problems with haemolysins are eliminated, transmission of disease is reduced, and the risk of Graft versus Host disease is lowered. Reconstituted frozen cells are also more easily administered through a smaller needle than is possible for routinely packed cells.
The transfusion of cold bank blood to a neonate may produce hypothermia and cardiac arrythmias. However, the routine use of a blood warmer is not recommended. In nonurgent situations the blood can be left at room temperature for up to 30 minutes and allowed to warm up before use. Occasionally, with an emergency such as a shocked baby, it may be necessary to warm the blood using a disposable coil, but meticulous attention must be paid to the prevention of haemolysis from too high a temperature in the water bath. Uncontrolled water baths, hot water from the tap, radiant heat, etc., are contraindicated.
Before leaving the subject of the neonate it is pertinent to point to a further hazard that occurs more often than it should, namely, "investigational anaemia" from repeated blood sampling for laboratory tests. Samples removed should be recorded in the ward notes and a careful check carried out on the total volume taken.
CARDIOPULMONARY BY-PASS
Apart from the problems inherent in the manipulation of sterile liquid blood outside the body, most of the hazards associated with bypass procedures, that have been described, relate to disorders of haemostasis and include:
(i) thrombocytopenia (ii) clotting factor V & VIII deficiencies (iii) incomplete neutralisation of heparin (iv) disseminated intravascular coagulation (DIC) consequent upon hypovolaemia and poor perfusion (v) damage to red cells in the extracorporeal circuit. The nature of haemostatic defects in this context has been the subject of much debate. Most workers have noted abnormalities in levels of clotting factors 11, V, VIII and X, low fibrinogen levels and raised degradation products and, in addition, low platelet counts have been recorded.
Functional platelet defects have been thought to underlie most bleeding diatheses. However, Umlas 7 demonstrated that bleeding times and platelet counts in by-pass surgery patients followed the same correlation as that of the normal population. From a quantitative aspect a platelet count of 90x 1 0 9 /1 can be considered a critical level for haemostasis. 8 ,9 Occasionally, by-pass patients do bleed excessively and it is difficult to distinguish between the effects of cardiopulmonary by-pass and those associated with the massive transfusion required to maintain the patient's blood volume under these circumstances.
Repeat by-pass procedures tend to bleed excessively from cut scar tissue at higher platelet levels and it may be very difficult to distinguish this from surgical bleeding. Platelet concentrates may be indicated but their use should be highly selective.
If the by-pass procedure is short and without complications, and if excessive amounts of "aged" blood are not used, platelet counts return to normal within a few hours after bypass is ended. 9 With longer procedures involving more stored blood there may be an immediate rebound of platelets after by-pass, which falls again to remain low (usually < 90,000) for 4 or 5 days after surgery.
Fibrinogen levels fall progressively during by-pass but return to normal quickly after the procedure is concluded.
Poor per fusion during by-pass or when the heart has taken over again may result in significant DIe. Delay in heparin neutralisation may help to control this problem but it is essential to maintain a normal blood volume with an adequate circulation. There is no convincing evidence that the use of fresh frozen plasma is beneficial in these circumstances. Table 1 lists the causes and outcome of haemorrhagic complications in 7 out of 300 cases undergoing cardiopulmonary by-pass procedures in Brisbane up to June 9, 1970 . This Anaesthesia and Intensive Care. Vol. VI/I, No. 2, l'vfay, 1980 period was chosen because it covered the beginning of cardiac surgery at the Prince Charles Hospital and consequently reflects a period of relative inexperience in the management of patients undergoing cardiopulmonary by-pass. The criteria covering the selection of blood for these cases has remained unaltered since they were established just before the beginning of heart surgery in this centre. The Transfusion Service supplies blood of less than 5 days storage and up to one litre of this is less than 24 hours old on the day of operation. The latter is given as the patient comes off by-pass. 
SPECIFIC ORGAN FAILURE
(a) The cardiovascular system (eVS) Hypervolaemia occurring in patients with a compromised cardiovascular system may provoke the onset of congestive cardiac failure and pulmonary oedema. Accordingly, transfusion is indicated only when there are symptoms of hypoxia affecting the CVS or the central nervous system (CNS).
Various precautions are recommended. (i) Restrict the rate and volume of blood to be given. Whole blood is contraindicated. An initial transfusion of not more than the packed cells from one unit of blood should be given over a period of 6 hours. The patient should be reviewed 24 hours later and, if necessary, the transfusion is repeated. NOTE: Transfusions of this nature should not be administered overnight unless the patient receives special nursing attention.
(ii) The venous pressure should be carefully monitored. In general, if this is normal before the transfusion begins it is unlikely that congestive cardiac failure will develop.
(iii) With any degree of cardiac failure (or renal failure) the use of diuretics such as frusemide may be indicated prior to transfusion, or even during the procedure.
(iv) A modified exchange transfusion may be of value. Removal of whole blood with replacement by concentrated red cells helps to prevent circulatory overload, and effectively raises the oxygen carrying capacity of the blood.
(v) Warming the patient. This induces vasodilation and may increase the vascular capacity by up to 250 m!.
In summary, unless the indications for transfusion are urgent the procedure is not justified.
(b) The liver Anaemia occurs commonly in patients with liver disease and may be due to blood loss, haemolysis or marrow depression. Liver failure is often associated with an increased cardiac output and in patients with cirrhosis the plasma volume may be increased. Various metabolic disturbances such as acidosis with hyperkalaemia and hyponatremia may occur together with an oliguria from a functional renal failure (hepatorenal syndrome). Blood transfusion accordingly may be a hazardous procedure.
Bleeding from the nose, oesophageal varices, acute gastric erosion, peptic ulceration or haemorrhoids may precipitate a situation in which blood transfusion becomes an urgent requirement. Restoration of blood volume is imperative and may require a massive transfusion for correction.
Deficiencies of the vitamin K-dependent clotting factors are common in liver failure and together with reduction in fibrinogen activity (both qualitative and quantitative) may contribute towards the haemostatic defect. Thrombocytopenia may also be a contributing factor.
The use of fresh blood, platelet concentrates, cryoprecipitate-poor plasma, and occasionally fresh frozen plasma, may provide short-term correction of the haemorrhagic state, but the use of prothrombin complex clotting factors should be avoided as the haemostatic defect may be aggravated.
(c) The kidney Anaemia is an almost invariable accompaniment of chronic renal failure and may result from many causes including:
(i) anaemia of chronic infection (ii) blood loss -renal tract, gastro-intestinal tract or haemodialysis (iii) folate deficiency (iv) haemolysis (v) in the absence of obvious cause ?erythropoietin production impaired. The regulation of body water and electrolytes is impaired in renal failure and hydraemia or dehydration may occur. The apparent degree of anaemia may accordingly be exaggerated or diminished.
In patients with renal insufficiency the increase in blood volume following transfusion is far more prolonged than in normal subjects. 1O Because of this the expected rise in haemoglobin may be delayed for a day or two and lead to the suspicion that the transfused cells have been eliminated. The end result may well be a further transfusion which is neither necessary nor well tolerated by the patient.
Anaemia can be a problem in haemodialysis but unless transplantation is contemplated it is probably better to withhold transfusion and to concentrate on reducing azotaemia to a state where the anaemia is well tolerated.
Until relatively recently it was believed that blood transfusion reduced the chances of survival of a renal graft and hence most nephrologists carefully avoided this apparent hazard. It is now established that blood transfusion has a powerful effect in prolonging renal survival of renal grafts and that this effect is proportional to the number of transfusions given. II ,12,IJ 4. AUTO-IMMUNE HAEMOLYTIC ANAEMIA (AI HA) (Warm acting antibodies) As a general rule it is preferable to avoid blood transfusion altogether in a patient with AIHA. Occasionally however there are circumstances in which it cannot be avoided and, in such cases, the principle to follow is to 4naeHhesia and Il1len5h'c Care, Vol. 1'/1/, /\'0. 2 • . Way, 1980 give least amount necessary to achieve the desired clinical effects. The aim of such transfusion is to tide the patient over a particularly stormy episode in the course of the illness and not to attempt complete correction of the anaemic state.
The selection of blood to be used in these cases may be a very difficult task particularly if there are free antibodies in the serum. The difficulty is compounded if there is a history suggesting the possibility of previous alloimmunisation to blood group antigens.
Cross-matching tests must be performed using serum as well as an eluate from the patient's cells in parallel, since the specificities of fixed and free antibodies may be different.
There are three approaches to the final selection of blood to be used:
(i) On the basis that most auto-antibodies have their specificity directed within the Rh system, blood is selected that has the same Rh phenotype as the recipient, and does not give stronger reactions than the auto-control. Hopefully, the assumption is made that the risk of aBo-immunisation is reduced and the transfused cells will survive as long as the recipient's own cells. The latter assumption is probably incorrect.
(ii) Donor units are selected that give the least incompatibility according to in vitro test results. This is probably the most satisfactory course to follow in an emergency.
(iii) The best way to select donor units in a particular case is to perform a biological test of compatibility by measuring the survival of isotope-tagged red cells. Survival of 70070 or Anaesthesia and Intensive Care, Vol. VIII, No. 2. May. 1980 more cells after 24 hours indicates that the transfusion will be reasonably safe.
